Multimodality focal therapy for prostate cancer: outcome of the à la carte approach in clinical practice

Multimodality FT with <i>à la carte</i> approach provides versatility in ablative strategies and offers a reasonable functional and oncological outcome for low- to intermediate-risk prostate cancer.

Authors

Institutions

Publication Details

Journal
Prostate International
Published
2025-03-25
DOI
https://doi.org/10.1016/j.prnil.2025.03.006
Citations
3
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodality focal therapy for prostate cancer: outcome of the à la carte approach in clinical practice

C. Cho, Aq Liu, Chi‐Hang Yee, C. Chan et al.
3 citations
Prostate International
Prostate Cancer Diagnosis and Treatment
4.56
article

Multimodality focal therapy for prostate cancer: outcome of the à la carte approach in clinical practice

C. Cho, Aq Liu, Chi‐Hang Yee, C. Chan, Raymond J. Chan, C.F. Ng, Hsiang-Yi Hung, Ka-Lun Lo, Pinhsuan Chiu, Whc Chan, Jyc Teoh, Helen Wong
article en
3 citations

Abstract

Multimodality FT with <i>à la carte</i> approach provides versatility in ablative strategies and offers a reasonable functional and oncological outcome for low- to intermediate-risk prostate cancer.

Prostate InternationalVol. 13(4)
Chinese University of Hong Kong (HK), Prince of Wales Hospital (CN)
Good health and well-being
Openalex Percentile: Top 6%
Prostate Cancer Diagnosis and Treatment
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.